Dublin, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The "Sequencing Reagents Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030" report has been added to ResearchAndMarkets.com's offering.
This report on the global sequencing reagents market reveals promising growth prospects, with the market expected to reach USD 8.31 billion by 2030, reflecting a robust CAGR of 7.75% during the forecast period from 2021 to 2030.
In 2022, the market generated USD 4.75 billion in revenue, driven by advancements in DNA sequencing technologies and the decreasing cost of sequencing. The study encompasses qualitative and quantitative analyses, with a focus on leading geographies, including North America, Europe, Asia Pacific, and the Rest of the World, providing valuable insights for stakeholders in the life sciences sector.
Key Market Insights:
- Significant Growth in Sequencing Reagents Market: The sequencing reagents market is a vital segment of the life sciences sector, playing a crucial role in DNA sequencing processes. These reagents, which consist of modified nucleotides labeled with fluorescent dyes, have seen increased demand due to their role as building blocks for sequencing reactions.
- Impact of DNA Sequencing Costs: The decreasing price of DNA sequencing has made it more accessible to academic institutions, medical professionals, and diagnostic laboratories. This affordability has driven market growth.
- Next-Generation Sequencing (NGS) Revolution: NGS technology has revolutionized genomics research, enabling a wide range of applications, including whole genome sequencing, exome sequencing, transcriptome sequencing, and targeted sequencing. Library preparation kits, polymerases, adapters, indexing reagents, and buffers are among the essential sequencing reagents for NGS.
- North America Leads the Way: North America holds a significant share of the global sequencing reagents market. Factors such as the presence of major pharmaceutical and biotechnology companies, cutting-edge research institutions, and a well-established healthcare infrastructure contribute to the region's leadership in genomics research and NGS technology adoption.
Report Findings:
Drivers:
- Rapid adoption of sequencing technologies.
- Decreasing DNA sequencing costs, enhancing accessibility.
Restraints:
- Lack of increasing regulations for Next-generation Sequencing (NGS) techniques.
Opportunities:
- Increased investment in R&D for sequencing technologies.
Market Segmentation:
The global sequencing reagents market is segmented into:
By Type:
- Template Kits
- Library Kits
- Control Kits
- Sequencing Kits
- Others
By Technology:
- Next Generation Sequencing
- Sanger Sequencing
- Third Generation Sequencing
By End User:
- Hospitals and Clinics
- Research Institutes
- Pharmaceutical and Biotechnology Companies
- Others
Company Profiles:
The report profiles key companies operating in the global sequencing reagents market, including:
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- QIAGEN
- Oxford Nanopore Technologies plc.
- Agilent Technologies, Inc.
- Takara Bio Inc.
- BD
- Archer (now part of Integrated DNA Technologies, Inc.)
- F. Hoffmann-La Roche Ltd
- Meridian Bioscience Inc.
Report Highlights:
- Comprehensive analysis of the global and regional sequencing reagents market.
- In-depth coverage of market segments, trends, developments, and market size forecasts up to 2030.
- Detailed analysis of companies, including product portfolios, revenue, SWOT analysis, and recent developments.
- Insights into growth opportunities for market players, helping them make informed investment decisions.
For more information about this report visit https://www.researchandmarkets.com/r/2666gm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
